Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Finn

Showing results (431-440 of 527) with videos related to

Pageof 53
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2024
A conserved molecular logic for neurogenesis to gliogenesis switch in the cerebral cortexXiaoyi G Liang, Kendy Hoang, Brandon L Meyerink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2022
Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose ChemotherapyZev A Wainberg, Arun S Singh, Gottfried E Konecny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trialH S Rugo, V Diéras, K A Gelmon, et al.
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
The Lancet. Oncology|January 24, 2025
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b-2, studyRichard S Finn, Baek-Yeol Ryoo, Chih-Hung Hsu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 9, 2017
Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selectionColin M Court, Michael P Harlander-Locke, Daniela Markovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancerMichael F Press, Richard S Finn, David Cameron, et al.
Molecular Cancer Therapeutics|February 28, 2013
Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cellsGottfried E Konecny, Teodora Kolarova, Neil A O'Brien, et al.
Hepatology Communications|October 7, 2020
Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint InhibitorsPaul Winograd, Shuang Hou, Colin M Court, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancerJoyce O'Shaughnessy, Lee Schwartzberg, Michael A Danso, et al.
Pageof 53

Showing results (431-440 of 527) with videos related to

Sort By:
Pageof 53
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2024
A conserved molecular logic for neurogenesis to gliogenesis switch in the cerebral cortexXiaoyi G Liang, Kendy Hoang, Brandon L Meyerink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2022
Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose ChemotherapyZev A Wainberg, Arun S Singh, Gottfried E Konecny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trialH S Rugo, V Diéras, K A Gelmon, et al.
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
The Lancet. Oncology|January 24, 2025
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b-2, studyRichard S Finn, Baek-Yeol Ryoo, Chih-Hung Hsu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 9, 2017
Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selectionColin M Court, Michael P Harlander-Locke, Daniela Markovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancerMichael F Press, Richard S Finn, David Cameron, et al.
Molecular Cancer Therapeutics|February 28, 2013
Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cellsGottfried E Konecny, Teodora Kolarova, Neil A O'Brien, et al.
Hepatology Communications|October 7, 2020
Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint InhibitorsPaul Winograd, Shuang Hou, Colin M Court, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancerJoyce O'Shaughnessy, Lee Schwartzberg, Michael A Danso, et al.
Pageof 53